133 related articles for article (PubMed ID: 3105246)
1. In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Digranes A
Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):29-32. PubMed ID: 3105246
[TBL] [Abstract][Full Text] [Related]
2. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Digranes A; Benonisen E; Salveson A; Zahm F
Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of amifloxacin and two of its metabolites.
Venezia RA; Prymas LA; Shayegani A; Yocum DM
Antimicrob Agents Chemother; 1989 May; 33(5):762-6. PubMed ID: 2751287
[TBL] [Abstract][Full Text] [Related]
8. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
Digranes A; Dibb WL
Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Fass RJ; Helsel VL
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):293-9. PubMed ID: 3107872
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Chau PY; Leung YK; Ng WW
Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Chin NX; Neu HC
J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
[TBL] [Abstract][Full Text] [Related]
18. North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.
Jones RN; Hoban DJ
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):49-56. PubMed ID: 8026157
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
Adeyemi-Doro FA; Rotowa NA
Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
